Regina Hodits

Managing Partner at Wellington Partners

Regina is a Managing Partner at Wellington Partners Life Sciences and represents the WPLS funds on the Boards of Ayoxxa, Carisma, SNIPR and Stipe. She served on the Board of Themis (acquired by MSD), was a founding investor in Rigontec (acquired by MSD), Sapiens (acquired by Medtronic), Middle Peak Medical (acquired by Symetis / Boston Scientific), and has until recently been the Spokesperson for the Board of the German PE and Venture Capital Association (BVK). Since joining the industry in 2000, she has become an influential investor in the European venture capital industry, focusing on early-stage and growth deals in Life Sciences.